An early coronavirus vaccine rollout? Be careful what you wish for…

Following reports that 30 people died in Norway after receiving the Pfizer vaccine, the government, its health officers and Pfizer have all been falling over themselves, assuring us the vaccine is safe.

Notwithstanding these assurances, it is imperative that safety concerns be addressed in detail. Professor Paolo Bellavite, of the University of Verona Medical School, whose expertise is in experimental medicine and innate immunity, argues that the Pfizer vaccine clinical trials concluded far too soon. Without a proper assessment over time of any potential adverse effects, we will not know the answer to a fundamental question: will the vaccine do more harm than good? 

Professor Bellavite notes the Pfizer trials do not address…